A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study aims to evaluate the efficacy of Adebrelimab plus concurrent chemoradiotherapy compared with placebo plus concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer by evaluating progression-free survival (PFS).
Epistemonikos ID: 110055e5e56a6fac77cdaad449621ecc6972fa3c
First added on: Sep 12, 2025